stockrowBruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.
- Revenue
- +1.57%
- EPS
- −75.4%
- Free cash flow
- +278.7%
- Total debt
- −14.7%
Quarter to September 2026, against a year earlier
Follow BRKR
Alert me
Bruker Corporation (BRKR) Gross margin
Bruker Corporation's gross margin over the twelve months to 30 September 2026 was 47.7%, up 1.8 percentage points from fiscal 2025 (45.9%). Over the past ten years it has ranged from 43.6% (fiscal 2015) to 51.6% (fiscal 2022); the current reading is higher than 18% of that period. That is below the Medical Devices industry median of 57.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 45.9% | (3.09) |
| FY2024 | 49.0% | (2.05) |
| FY2023 | 51.1% | (0.54) |
| FY2022 | 51.6% | 1.56 |
| FY2021 | 50.0% | 2.74 |
| FY2020 | 47.3% | (0.73) |
| FY2019 | 48.0% | 0.54 |
| FY2018 | 47.5% | 1.27 |
| FY2017 | 46.2% | (0.04) |
| FY2016 | 46.3% | 2.61 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 49.1% | (0.49) |
| Jun 2026 | 49.6% | 3.48 |
| Mar 2026 | 46.1% | 0.16 |
| Dec 2025 | 46.0% | 1.88 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation compare | 81.1% |
| PODD Insulet Corporation compare | 71.9% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| TXG 10x Genomics compare | 70.0% |
| GMED Globus Medical, Inc. compare | 69.1% |
| PEN Penumbra, Inc. compare | 68.0% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 51.3% |
| BIO Bio-Rad Laboratories, Inc. compare | 51.3% |
| BRKR Bruker Corporation | 47.7% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on BRKR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement